Related Articles
RANKL-induced migration of MDA-MB-231 human breast cancer cells via Src and MAPK activation
Inhibition effects of total flavonoids from Sculellaria barbata D. Don on human breast carcinoma bone metastasis via downregulating PTHrP pathway
C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway
Proteasome inhibitor bortezomib (PS-341) enhances RANKL-induced MDA-MB-231 breast cancer cell migration
Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer